We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis (DOTAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00783536
Recruitment Status : Withdrawn
First Posted : October 31, 2008
Last Update Posted : June 2, 2009
Information provided by:
Wyeth is now a wholly owned subsidiary of Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2010
  Estimated Study Completion Date : June 2010